Threshold Pharmaceuticals, Inc. (THLD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Threshold Pharmaceuticals, Inc. (THLD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Threshold Pharmaceuticals, Inc. (THLD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Threshold Pharmaceuticals, Inc. (THLD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
25 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Threshold Pharmaceuticals, Inc. (Threshold) is a biotechnology company that discovers and develops tumor-targeted therapies. The companys clinical pipeline includes TH-CR-406, MAESTRO, TH-CR-413, TH-CR-408, TH-IST-4003, TH-IST-4004, TH-CR-410, TH-CR-407 and TH-IST-4001. Its products include evofosfamide, TH-4000 and [18F]-HX4. Thresholds evofosfamide and TH-4000 are under evaluation for the treatment of a variety of tumor types. The companys [18F]-HX4 is an in-licensed positron emission tomography imaging agent for hypoxia.

Threshold Pharmaceuticals, Inc. (THLD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials a

  
Source:
Document ID
GDPH82164D
Country
Industry
Ticker
THLD=US
Company
Threshold Pharmaceuticals, Inc.
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Threshold Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Threshold Pharmaceuticals, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Threshold Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Threshold Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Threshold Pharmaceuticals, Inc., Medical Devices Deals, 2010 to YTD 201691
Threshold Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
Threshold Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deal Details1111
  Partnerships111
    Threshold Pharma and Merck Terminates Agreement111
    Merck Serono Enters Into Co-Development Agreement With Threshold Pharma For TH-302, Cancer Drug122
  Equity Offering141
    Threshold Pharma Prices Public Offering of Shares and Warrants for USD30 Million142
    Threshold Pharma Files Amended Registration Statement For Public Offering Of Shares For US$15 Million162
    Threshold Pharma Completes Public Offering Of Shares For US$2.6 Million182
    Threshold Pharma Completes Registered Direct Offering Of US$30 Million202
Threshold Pharmaceuticals, Inc. - Key Competitors221
Key Employees231
Locations And Subsidiaries241
  Head Office241
Appendix251
  Methodology251
  About GlobalData251
  Contact Us251
  Disclaimer251

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Threshold Pharmaceuticals, Inc. (THLD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Threshold-Pharmaceuticals-Inc-THLD-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7717>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Threshold Pharmaceuticals, Inc. (THLD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Threshold-Pharmaceuticals-Inc-THLD-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7717>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research